Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY1R | P25929 | 3/20 | 0.56 |
| ▸ | NPY2R | P49146 | 3/20 | 0.56 |
| ▸ | NPY4R | P50391 | 3/20 | 0.56 |
| ▸ | ERAP2 | Q6P179 | 3/20 | 0.56 |
| ▸ | GHSR | Q92847 | 2/20 | 0.56 |
| ▸ | IL1RN | P18510 | 2/20 | 0.55 |
| ▸ | ERAP1 | Q9NZ08 | 2/20 | 0.55 |
| ▸ | CCKBR | P32239 | 2/20 | 0.53 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.53 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14552702 | 0.97 | GHSR (0.57) | NPY1RNPY2RNPY4RERAP2GHSR | |
| SCHEMBL17880376 | 0.97 | GHSR (0.57) | NPY1RNPY2RNPY4RERAP2GHSR | |
| SCHEMBL14553988 | 0.97 | GHSR (0.57) | NPY1RNPY2RNPY4RERAP2GHSR | |
| SCHEMBL18899117 | 0.94 | GHSR (0.59) | NPY1RNPY2RNPY4RGHSR | |
| SCHEMBL30291169 | 0.90 | ERAP2 (0.58) | NPY1RNPY2RNPY4RERAP2GHSR | |
| SCHEMBL18257005 | 0.89 | ERAP2 (0.57) | NPY1RNPY2RNPY4RERAP2GHSR | |
| SCHEMBL17877082 | 0.89 | ERAP2 (0.57) | NPY1RNPY2RNPY4RERAP2GHSR | |
| SCHEMBL31146519 | 0.89 | GHSR (0.61) | NPY1RNPY2RNPY4RGHSR | |
| SCHEMBL18256998 | 0.89 | ERAP2 (0.57) | NPY1RNPY2RNPY4RERAP2GHSR | |
| SCHEMBL18079764 | 0.89 | ERAP2 (0.57) | NPY1RNPY2RNPY4RERAP2GHSR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9101687-B2 | Beta sheet tapes ribbons in tissue engineering | UNIVERSITY OF LEEDS (GB) | 2015-08-11 | — | — | US | disclosed |
| US-20130012457-A1 | BETA SHEET TAPES RIBBONS IN TISSUE ENGINEERING | THE UNIVERSITY OF LEEDS | 2013-01-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130012457-A1 | BETA SHEET TAPES RIBBONS IN TISSUE ENGINEERING | IAPP, TAGLN2, KRT18 | NPY1R 3085/4885NPY2R 2895/4885NPY4R 3380/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.